Direkt zum Inhalt
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Suche
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIÖffnen dieses Hauptmenu Punktes
    • Research Initiatives
    • Ethics and Research integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsÖffnen dieses Hauptmenu Punktes
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Scientific Computing, Theory and Data
    • Large Research Facilities
  • Facilities and InstrumentsÖffnen dieses Hauptmenu Punktes
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesÖffnen dieses Hauptmenu Punktes
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • New ProjectsÖffnen dieses Hauptmenu Punktes
    • SLS 2.0
    • IMPACT
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

Sie befinden sich hier:

  1. PSI Home
  2. Labs & User Services
  3. PSD
  4. LSB
  5. MX Group
  6. Scientific Highlights and News
  7. First MX results of the priority COVID-19 call

Sekundäre Navigation

Macromolecular Crystallography Group

  • People
  • Beamlines
  • MX Industry
  • Research
  • Scientific Highlights and News
  • Publications
  • Nützliche Links

  • PX I (X06SA)
  • PX II (X10SA)
  • PX III (X06DA)

Info message

Dieser Inhalt ist nicht auf Deutsch verfügbar.
15. Mai 2020

First MX results of the priority COVID-19 call

Beamline X06SA-PXI

Scientists from the Goethe University in Frankfurt am Main, Germany have published results on the papain-like protease (PLpro), an essential enzyme of SARS-CoV-2. The structural biology work was performed at the macromolecular crystallography beamline X06SA-PXI at SLS following the opening of the "PRIORITY COVID-19 Call”. The paper was submitted within one month after answering the proposal call. The crystallographic data collection happened on the 9th of April after the planned Easter shutdown of the SLS was cancelled for this specific experiment.

The protease PLpro is required for the processing of viral polypeptides and the assembly of new viral particles within human cells. In addition, SARS-CoV-2 uses this enzyme to dampen the anti-viral immune response, helping the virus to modulate the host’s immune system to its own benefit. By this, the virus can easily multiply and spread further. The team has demonstrated that pharmaceutical targeting of PLpro by a non-covalent inhibitor (GRL-0617) blocks virus spread and increases anti-viral immunity in human epithelial cells, the prime site of pathogen entry.

The respective results were made publicly available on a preprint server. The PDB 6YVA was released on the 13th of May.

Structural analysis of SARS-CoV-2 PLpro in complex with full length ISG15
Structural analysis of SARS-CoV-2 PLpro in complex with full length ISG15
Contact

Dr. Vincent Olieric, Swiss Light Source
Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
Phone: +41 56 310 5233, e-mail: vincent.olieric@psi.ch

Dr. Meitian Wang, Swiss Light Source
Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
Phone: +41 56 310 4175, e-mail: meitian.wang@psi.ch

Media release

https://www.biochem2.com/newsentry/2020-05-05
 

Publications

Inhibition of papain-like protease PLpro blocks SARS-CoV-2 spread and promotes anti-viral immunity
Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher, Paul P. Geurink, Gerbrand J. van der Heden van Noort, Huib Ovaa, Klaus- Peter Knobeloch, Krishnaraj Rajalingam, Brenda A. Schulman, Jindrich Cinatl, Gerhard Hummer, Sandra Ciesek, Ivan Dikic
http://doi.org/10.21203/rs.3.rs-27134/v1

Mit Sidebar

Associated Beamlines

  • PX I (X06SA)
  • PX II (X10SA)
  • PX III (X06DA)

Contact

Head of MX
and Group Leader
Dr. Meitian Wang
Telephone: +41 56 310 4175
E-mail: meitian.wang@psi.ch


Group Leader MX
Application
Katherine McAuley
Telephone: +41 56 310 3979
E-mail: katherine.mcauley@psi.ch


Group Leader MX Instrumentation
Wayne Glettig
Telephone: +41 56 310 5823
E-mail: wayne.glettig@psi.ch


Group Leader MX Samples
Dr. May Sharpe née Marsh
Telephone: +41 56 310 5437
E-mail: may.sharpe@psi.ch


Group Leader MX Data
Dr. Justyna Aleksandra Wojdyla
Telephone: +41 56 310 5428
E-mail: justyna.wojdyla@psi.ch

top

Fussbereich

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Schweiz

Telefon: +41 56 310 21 11
Telefax: +41 56 310 21 99

Der Weg zu uns
Kontakt

Besucherzentrum psi forum
Schülerlabor iLab
Zentrum für Protonentherapie
PSI Bildungszentrum
PSI Guest House (in english)
PSI Gastronomie
psi forum-Shop

 

Service & Support

  • Telefonbuch
  • User Office
  • Accelerator Status
  • Publikationen des PSI
  • Lieferanten
  • E-Rechnung
  • Computing
  • Sicherheit

Karriere

  • Arbeiten am PSI
  • Stellenangebote
  • Aus- und Weiterbildung
  • Career Center
  • Berufsbildung
  • PSI Bildungszentrum

Für die Medien

  • Das PSI in Kürze
  • Zahlen und Fakten
  • Mediacorner
  • Medienmitteilungen
  • Social Media

Folgen Sie uns: Twitter (deutsch) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Impressum
  • Nutzungsbedingungen
  • Editoren-Login